Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunotherapy for cancer: an overview.

J W Proctor, M G Lewis, P W Mansell

    Canadian Journal of Surgery. Journal Canadien De Chirurgie
    |January 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Leprosy in Massachusetts-Its Diagnosis and Segregation.

    American journal of public hygiene·2009
    Same author

    Macaques co-immunized with SIVgag/pol-HIVenv and IL-12 plasmid have increased cellular responses.

    Journal of medical primatology·2007
    Same author

    Macaque dendritic cells infected with SIV-recombinant canarypox ex vivo induce SIV-specific immune responses in vivo.

    AIDS research and human retroviruses·2004
    Same author

    ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.

    Journal of virology·2001
    Same author

    Impairment of Gag-specific CD8(+) T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques.

    Journal of virology·2001
    Same author

    Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes.

    Nature medicine·2001
    Same journal

    Trends in the incidence and surgical treatment of hepatocellular carcinoma in Ontario.

    Canadian journal of surgery. Journal canadien de chirurgie·2026
    Same journal

    Referral patterns and wait times in complex peripheral nerve injuries: a review of a multidisciplinary clinic in Canada.

    Canadian journal of surgery. Journal canadien de chirurgie·2026
    Same journal

    Cost of hospital admission after autologous breast reconstruction and factors associated with increased cost: a population-based cohort study.

    Canadian journal of surgery. Journal canadien de chirurgie·2026
    Same journal

    Outpatient surgical referrals from primary care providers for people experiencing homelessness: a retrospective review.

    Canadian journal of surgery. Journal canadien de chirurgie·2026
    Same journal

    Management of cystic echinococcosis in British Columbia: outcomes and suggestions to improve guideline adherence.

    Canadian journal of surgery. Journal canadien de chirurgie·2026
    Same journal

    Practical solutions for complex surgical problems: right operation, right place, right time: General Surgery Atlantic Conference 2026, May 22-24, 2026, Fox Harb'r Resort, Fox Harbour, Nova Scotia.

    Canadian journal of surgery. Journal canadien de chirurgie·2026
    See all related articles

    Cancer immunotherapy targets cancer cells but is often ineffective, especially in metastatic disease. Further research and targeted trials are needed to improve its use as an adjunctive cancer treatment.

    Area of Science:

    • Oncology
    • Immunology

    Background:

    • Cancer immunotherapy offers targeted treatment, sparing normal cells.
    • Current immunotherapy methods face challenges, particularly in widespread metastatic cancer.
    • Occasional positive outcomes highlight immunotherapy's potential despite general ineffectiveness.

    Purpose of the Study:

    • To explore the potential of cancer immunotherapy as a targeted treatment.
    • To address the limitations and challenges associated with existing immunotherapy approaches.
    • To advocate for small-scale experimental trials in selected patient groups.

    Main Methods:

    • Focus on immunotherapy directed specifically at cancer cells.
    • Intensive investigation of patients' immunologic status in relation to their tumors.

    Related Experiment Videos

  • Small-scale experimental trials in highly selected patient cohorts.

    • Main Results:

    • Immunotherapy is generally ineffective, particularly in patients with widespread metastatic disease.
    • Despite limitations, immunotherapy occasionally yields positive results.
    • Existing methods have inherent problems requiring further innovation.

    Conclusions:

    • Immunotherapy shows promise as an adjunct to existing cancer therapies.
    • Further research and targeted trials are crucial for optimizing immunotherapy.
    • The future of immunotherapy lies in its role in controlling residual tumor and potentially curing it.